Klin Farmakol Farm. 2016;30(1):5-10 | DOI: 10.36290/far.2016.002

The use of goldenrod general (Solidago virgaurea) preparations does not influence the metabolism of concomitantly administered drugs

Veronika Tománková1, Adéla Vlčková1, Pavel Anzenbacher2, Petr Bachleda3, Eva Anzenbacherová1
1 Ústav lékařské chemie a biochemie, Lékařská fakulta Univerzity Palackého, Olomouc
2 Ústav farmakologie, Lékařská fakulta Univerzity Palackého, Olomouc
3 II. chirurgická klinika, Fakultní nemocnice Olomouc

Purpose: Solidago virgaurea „goldenrod“ is a known medicinal plant that has been used since ancient times (1, 2). The genus Solidago

is interesting in terms of both biological effects and the presence of many interesting secondary metabolites – flavonoids,

phenolic acids and glucosides, polysaccharides and others (3). Solidago virgaurea is known to exhibit diuretic, antiinflammatory

and newly described antitumoral, antimicrobial, sedative and hypotensive effects (1, 2). Primarily flavonoids and phenolic diglucoside

– leiocarposide belong to secondary metabolites having primarily a positive effect on diuresis (3). Our objective was to

investigate whether Solidaginis virgaureae herba extract, decoction and leachate affect the properties of phase I biotransformation

enzymes, namely cytochromes P450 in human liver microsomal fraction and also in primary cultures of human hepatocytes.

Methods: Different concentrations of Solidaginis virgaureae herba extract, decoction and leachate, expressed as mg of dry weight

in mL of water (0.042 mg/mL; 0.083 mg/mL and 0.167 mg/mL) were studied. Enzyme activities and protein expression were determined

using HPLC and Western blotting, respectively.

Results: Activity and protein expression of CYP1A2, CYP2A6, CYP2C9, CYP2D6 and CYP3A4 were only little influenced by Solidaginis

virgaureae herba preparations, either in human hepatocytes as well as in human liver microsomal fraction in all studied

concentrations.

Conclusion: Based on the results of the enzyme activities and the amount of protein can be expected that the Solidaginis virgaureae

herba preparations do not significantly affect the metabolism of concomitantly administered drugs and their use probably

does not result in drug interactions.

Keywords: Solidaginis virgaureae herba, cytochromes P450, primary cultures of human hepatocytes, human liver microsomal fraction, drug metabolism

Published: May 30, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tománková V, Vlčková A, Anzenbacher P, Bachleda P, Anzenbacherová E. The use of goldenrod general (Solidago virgaurea) preparations does not influence the metabolism of concomitantly administered drugs. Klin Farmakol Farm. 2016;30(1):5-10. doi: 10.36290/far.2016.002.

Download citation

References

  1. Kalemba D. Constituents of the essential oil of Solidago virgaurea L. Flavour Fragr J 1998; 13(6): 373-376. Go to original source...
  2. Dobjanschi L, Antonescu A, Zdrinca M, et al. HPLC-MS analysis of flavonoids obtained from Solidago sp. (Asteraceae). Analele Universitatii din Oradea, Fascicula: Protectia Mediului 2012; 19: 75-79.
  3. Thiem B, Wesolowska M, Skrzypczak L, Budzianowski J. Phenolic compounds in two Solidago L. species from in vitro culture. Acta Pol Pharm 2001; 58(4): 277-281. Go to PubMed...
  4. Apáti P, Szentmihályi K, Kristó ST, et al. Herbal remedies of Solidago-correlation of phytochemical characteristics and antioxidative properties. J Pharm Biomed Anal 2003; 32(4-5): 1045-1053. Go to original source... Go to PubMed...
  5. Jiang T, Huang BK, Qin LP. A survey of chemical and pharmacological studies on Solidago. Zhong Xi Yi Jie He Xue Bao 2006; 4(4): 430-435. Go to original source... Go to PubMed...
  6. Demir H, Acik L, Bali EB, Koc LY, Kaynak G. Antioxidant and antimicrobial activities of Solidago virgaurea extracts. Afr J Biotechnol 2009; 8(2): 274-279.
  7. Szymura M, Szymura TH. Soil preferences and morphological diversity of goldenrods (Solidago L.) from south-western Poland. Acta Soc Bot Pol 2013; 82(2): 107-115. Go to original source...
  8. Pyšek P, Danihelka J, Sádlo J, et al. Catalogue of alien plants of the Czech Republic (2nd edition): checklist update, taxonomic diversity and invasion patterns. Preslia 2012; 84: 155-255.
  9. Český Lékopis 2009, Solidaginis virgaureae herba (Nať zlatobýlu obecného) 6.0:1893 (díl 3, str. 3153-3154). Grada, Praha 2009.
  10. Yarnell E. Botanical medicines for the urinary tract. World J Urol 2002; 20(5): 285-293. Go to original source... Go to PubMed...
  11. Ghose R. Clinical consequences of altered drug disposition in obesity. J Clin Trials 2012; 1: e107. Go to original source...
  12. Anzenbacher P, Anzenbacherová E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 2001; 58(5-6): 737-747. Go to original source... Go to PubMed...
  13. Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 2008; 82(10): 667-715. Go to original source... Go to PubMed...
  14. Lin JH, Lu AY. Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 1998; 35(5): 361-390. Go to original source... Go to PubMed...
  15. Phillips IR, Shephard EA, Ortiz de Montellano PR, eds. Cytochrome P450 protocols. 3rd ed. New York, NY: Springer Science + Business Media, 2013: 987. Go to original source...
  16. Pichard L, Gillet G, Fabre I, et al. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab Dispos 1990; 18(5): 711-719.
  17. Sieuwerts AM, Klijn JG, Peters HA, Foekens JA. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival. Eur J Clin Chem Clin Biochem 1995; 33(11): 813-823. Go to original source... Go to PubMed...
  18. Chang TK, Waxman DJ. Catalytic assays for human cytochrome P450: an introduction. Methods Mol Biol 2006; 320: 73-83. Go to original source...
  19. Ohnishi N, Yokoyama T. Interactions between medicines and functional foods or dietary supplements. Keio J Med 2004; 53(3): 137-150. Go to original source... Go to PubMed...
  20. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2013; 4: 177. Go to original source...
  21. Maliakal PP, Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J Pharm Pharmacol 2001; 53(10): 1323-1329. Go to original source... Go to PubMed...
  22. Clare BA, Conroy RS, Spelman K. The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. J Altern Complement Med 2009; 15(8): 929-934. Go to original source... Go to PubMed...
  23. Kreydiyyeh SI, Usta J. Diuretic effect and mechanism of action of parsley. J Ethnopharmacol 2002; 79(3): 353-357. Go to original source... Go to PubMed...
  24. Jakovljevic V, Raskovic A, Popovic M, Sabo J. The effect of celery and parsley juices on pharmacodynamic aktivity of drugs involving cytochrome P450 in their metabolism. Eur J Drug Metab Pharmacokinet 2002; 27(3): 153-156. Go to original source... Go to PubMed...
  25. Matoušková P, Bártíková H, Boušová I, et al. Effect of defined green tea extract in various dosage schemes on drug-metabolizing enzymes in mice in vivo. J Funct Foods 2014; 10: 327-335. Go to original source...
  26. Chacko SM, Thambi PT, Kuttan R, Nishiqaki I. Beneficial effects of green tea: a literature review. Chin Med 2010; 5(13): 1-9. Go to original source... Go to PubMed...
  27. Brandin H, Viitanen E, Myrberg O, Arvidsson AK. Effects of herbal medicinal products and food supplements on induction of CYP1A2, CYP3A4 and MDR1 in human colon carcinoma cell line LS180. Phytother Res 2007; 21(3): 239-244. Go to original source... Go to PubMed...
  28. Nicolle LE. Epidemiology of urinary tract infections. Clin Microbiol Newsletter 2002; 24(18): 135-140. Go to original source...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.